Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$39.71 – $52.13
91% from low
Exchange
ARCX
ETF
Borrow rate
2.08%
Moderate
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PVALPutnam Focused Large Cap Value ETF | $51.01 | +0.12% | $5.5B | — |
| BKLCBNY Mellon US Large Cap Core Equity ETF | $142.06 | +1.23% | $5.5B | — |
| DIHPDimensional International High Profitability ETF | $33.98 | +0.64% | $6.1B | — |
| EEMViShares MSCI Emerging Markets Min Vol Factor ETF | $74.51 | +0.55% | $3.6B | — |
| FELGFidelity Enhanced Large Cap Growth ETF |
No company description on file.
No one on the platform currently holds PVAL.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 29,100 | $1.4M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-07 | $0.1405 | 2026-04-14 |
| 2025-12-19 | $0.1124 | 2025-12-23 |
| 2025-10-06 | $0.1029 | 2025-10-08 |
| 2025-07-07 | $0.1400 | 2025-07-09 |
| 2025-04-04 | $0.1010 | 2025-04-08 |
| 2024-12-05 | $0.1546 | 2024-12-09 |
| 2024-09-06 | $0.1210 | 2024-09-10 |
| 2024-06-06 | $0.1110 | 2024-06-10 |
| 2024-03-06 | $0.1110 | 2024-03-11 |
| 2023-12-06 | $0.2118 | 2023-12-11 |
No one on the platform has traded PVAL yet.
| $42.94 |
| +1.77% |
| $5.9B |
| — |
| GSIEGoldman Sachs ActiveBeta International Equity ETF | $45.48 | +0.54% | $5.8B | — |
| IVOOVanguard S&P Mid-Cap 400 ETF | $128.66 | -0.25% | $5.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-09-07 |
| $0.1110 |
| 2023-09-12 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News $NVO $PVAL $PPH https://stocktwits.com/news/equity/markets/nvo-stock-gains-as-uk-clears-first-daily-glp-1-weight-loss-pill-offsetting-security-breach-news/cZKTzonR72u
View on StockTwits ↗AZN Stock Rise As Wall Street Dismisses FDA Committee’s Rejection Of Breast Cancer Drug $AZN $PVAL $AVDE https://stocktwits.com/news/equity/markets/azn-stock-rise-as-wall-street-dismisses-fda-commitees-rejection-of-breast-cancer-drug/cZBMnogReIf
View on StockTwits ↗Novo Nordisk Launches Higher Dose Of Wegovy Injection Across US — Retail Thinks Stock Is ‘Terribly Undervalued’ $NVO $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-launches-higher-dose-of-wegovy-injection-across-us/cZJJyAuRIpU
View on StockTwits ↗Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy $NVO $PPH $PVAL https://stocktwits.com/news/equity/markets/novo-nordisk-wegovy-hd-7-2-mg-approved-by-fda/cZ3aFJgRIhX
View on StockTwits ↗Novo Nordisk-Hims Deal Turns Wall Street Bullish — BMO Sees Relief From Commercial Headwinds, BofA Upgrades HIMS Stock $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-hims-deal-turns-wall-street-bullish-hims-stock-upgrades/cZdos7IRI7d
View on StockTwits ↗HIMS Stock Soars After Novo Nordisk Drops Patent Infringement Lawsuit, Opens Access To Ozempic, Wegovy $HIMS $NVO $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/hims-stock-soars-novo-nordisk-drops-patent-suit-hims-hers-partnership-ozempic/cZdVZe7RIIk
View on StockTwits ↗Why Is NVO Stock Falling Pre-Market Today? $NVO $PPH $PVAL $AVDE $FTHI https://stocktwits.com/news/equity/markets/why-is-nvo-stock-falling-pre-market-today/cZRtZlKR4UC
View on StockTwits ↗Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly $NVO $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-reportedly-eyes-launching-wegovy-in-vials/cZb6rpcR4A0
View on StockTwits ↗FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/fda-novo-wegovy-pill-tv-advertisement-misleading-nvo-stock-pares-gains/cZbv5uwR4oX
View on StockTwits ↗Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-sues-hims-hers-permanent-ban-unapproved-compounded-drugs/cZbHzMjR4o2
View on StockTwits ↗$PVAL Volatility reflects unresolved questions around how strategy converts into durable results. Execution gaps should narrow meaningfully. Visible traction across indicators would support the story. Without confirmation, volatility likely persists.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.